1-3 of 3
Hai Vu Nguyen
Close
Sort by
Journal Articles

MYC-Alarmin Axis As a Novel Oncogenic Driver in a Subgroup of Triple Negative Myeloproliferative Neoplasms

Nicole D. Vincelette, Xiaoqing Yu, Andrew T. Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Hai Vu Nguyen, Erika Adriana Eksioglu, Onyee Chan, Najla H Al Ali, Parth C. Patel, Dae Hyun Lee, Shima Nakanishi, Renan Ferreira, Qianxing Mo, Suzanne Cory, Harshani Lawrence, Ling Zhang, Daniel Murphy, Rami S. Komrokji, Daesung Lee, Scott H. Kaufmann, John L. Cleveland, Seongseok Yun
Journal: Blood
Blood (2023) 142 (Supplement 1): 994.
https://doi.org/10.1182/blood-2023-174383
Published: 2023
Journal Articles

Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis

Hai Vu Nguyen, Cassandra J. Vandenberg, Ashley P. Ng, Mikara R. Robati, Natasha S. Anstee, Joel Rimes, Edwin D. Hawkins, Suzanne Cory
Journal: Blood
Blood (2020) 135 (13): 1019–1031.
https://doi.org/10.1182/blood.2019003014
Published: 2020
Includes: Supplemental data
Journal Articles

The Ets-1 transcription factor is required for Stat1-mediated T-bet expression and IgG2a class switching in mouse B cells

Hai Vu Nguyen, Enguerran Mouly, Karine Chemin, Romain Luinaud, Raymonde Despres, Jean-Paul Fermand, Bertrand Arnulf, Jean-Christophe Bories
Journal: Blood
Blood (2012) 119 (18): 4174–4181.
https://doi.org/10.1182/blood-2011-09-378182
Published: 2012
Includes: Supplemental data